MacroGenics raises $110M in follow-on

Days after its shares more than doubled based on a Phase III breast cancer readout, MacroGenics Inc. (NASDAQ:MGNX) raised $110 million in a follow-on.

MacroGenics sold 5.5 million shares at $20, pricing at a 5% discount to its Feb. 12 close of $20.99. The company proposed the offering after market hours that day, and priced later in the evening...